abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Operating Cash Flow (Statement)
-$1.22M
Quarterly · Period ending: · USD
HQL Operating Cash Flow (Statement)
Latest reported-$1.22Mperiod ending
Latest reported-$1.22Mperiod ending
HQL Quarterly Cash from Operations (-$750.00K → -$1.22M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
HQL operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -1,219,502 | |
| -1,275,359 | |
| -1,044,926 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -0 | |
| -0 | |
| 0 | |
| 0 | |
| -0 | |
| -0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -45,810 | |
| 45,810 | |
| -58,613 | |
| 6,048 | |
| 5,073 | |
| 2,200 | |
| 4,111,366 | |
| 16,993,733 | |
| 59,150,000 | |
| 59,150,000 | |
| 950,000 | |
| 950,000 | |
| 6,500,000 | |
| 6,500,000 | |
| 5,900,000 | |
| 5,900,000 | |
| -1,850,000 | |
| -1,850,000 | |
| -1,050,000 | |
| -1,050,000 | |
| -1,600,000 | |
| -1,600,000 | |
| -1,600,000 | |
| -1,600,000 | |
| -1,200,000 | |
| -1,200,000 | |
| -1,300,000 | |
| -1,300,000 | |
| -950,000 | |
| -950,000 | |
| -1,750,000 | |
| 50,000 | |
| -750,000 | |
| -750,000 | |
| -750,000 | |
| -750,000 |